PMID: 12767844May 28, 2003Paper

Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin-sulbactam treatment

The Journal of Hospital Infection
R SmolyakovJ Gilad

Abstract

The emergence of multidrug-resistant (MDR) Acinetobacter baumannii poses a therapeutic problem. The aim of this study was to assess the risk factors for nosocomial MDR-A. baumannii bloodstream infection (BSI) and the efficacy of ampicillin-sulbactam (A/S) in its treatment. Of 94 nosocomial A. baumannii BSI during the year 2000, 54% involved MDR strains, 81% of which were genetically related. Various risk factors for MDR-A. baumannii were found, of which intensive-care unit admission and prior aminoglycoside therapy were independently associated with MDR-A. baumannii acquisition on multivariate analysis. Of MDR-A. baumannii BSI cases, 65% received A/S and 35% inadequate antibiotic therapy, whereas of 43 non-MDR cases, 86% were treated according to susceptibility and 14% inappropriately with antibiotics to which these organisms were resistant. Crude mortality was comparable in the adequately treated groups. Respective mortalities among patients treated adequately and inadequately were 41.4 and 91.7% (p<0.001). Among severely ill patients, A/S therapy significantly decreased the risk of death (P=0.02 OR=7.64). MDR-A. baumannii has become highly endemic in our institution. A/S appears to be one of the last effective and safe empiri...Continue Reading

References

Feb 1, 1989·American Journal of Infection Control
Jun 1, 1988·American Journal of Infection Control·J S GarnerJ M Hughes
Jun 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J M CisnerosA R Cobacho
Feb 24, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·H SiauP C Woo
Feb 24, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·H WisplinghoffH Seifert
Aug 19, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A S LevinS F Costa
Jul 29, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·V M ManikalJ Quale
Oct 6, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·H WisplinghoffH Seifert
Jan 4, 2001·Journal of Clinical Microbiology·A SimhonM Shapiro
Aug 31, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J L García-GarmendiaM Gili-Miner
Aug 10, 2005·Seminars in Respiratory and Critical Care Medicine·J J Rahal, C Urban

❮ Previous
Next ❯

Citations

May 23, 2009·Archives of Gynecology and Obstetrics·Viktoria AivazovaIoannis Mylonas
Jun 6, 2008·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·D MarchaimM Weinberger
Nov 10, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J Moran-GiladY Carmeli
Mar 17, 2004·The Journal of Hospital Infection·A P Zavascki, A M Sandri
Apr 7, 2004·The Journal of Hospital Infection·T KendirliE Gökçay
Feb 1, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Pierre Edouard Fournier, Hervé Richet
Jun 16, 2010·Antimicrobial Agents and Chemotherapy·José-Manuel Rodríguez-MartínezLaurent Poirel
Jul 25, 2007·Antimicrobial Agents and Chemotherapy·Federico PerezRobert A Bonomo
Feb 8, 2006·Applied and Environmental Microbiology·Olivia GohlBeate Averhoff
Jul 16, 2008·Clinical Microbiology Reviews·Anton Y PelegDavid L Paterson
Jan 17, 2008·Drugs·Jacob Gilad, Yehuda Carmeli
Dec 17, 2008·Future Microbiology·Matteo BassettiLaura Nicolini
Mar 1, 2006·Vojnosanitetski pregled. Military-medical and pharmaceutical review·Vesna Suljagić, Veljko Mirović
Oct 14, 2011·Vojnosanitetski pregled. Military-medical and pharmaceutical review·Vesna SuljagićAleksandra Jovelić
Aug 2, 2013·Future Microbiology·Christopher Bogan, Dror Marchaim
May 7, 2013·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Lei HuangChang-Phone Fung
Jan 6, 2010·International Journal of Antimicrobial Agents·Nicola C Gordon, David W Wareham
Nov 22, 2008·The Lancet Infectious Diseases·Drosos E Karageorgopoulos, Matthew E Falagas
Jun 14, 2015·International Journal of Antimicrobial Agents·Matthew E FalagasNikolaos S Roussos
Aug 28, 2015·Journal of Research in Pharmacy Practice·Mandana Izadpanah, Hossein Khalili
Aug 10, 2005·Expert Opinion on Pharmacotherapy·Timothy R Pasquale, James S Tan
Jul 23, 2009·Expert Opinion on Drug Metabolism & Toxicology·Alex P Betrosian, Emmanuel E Douzinas
May 20, 2006·Scandinavian Journal of Infectious Diseases·Emine AlpMehmet Doganay
Dec 7, 2010·International Journal of Antimicrobial Agents·Ioannis K NeonakisEfthimia Petinaki
Nov 25, 2011·International Journal of Antimicrobial Agents·Marie Kempf, Jean-Marc Rolain
Jul 22, 2010·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Wang-Huei ShengShan-Chwen Chang
Aug 25, 2004·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Maria Cristina Bronharo TognimHélio S Sader
May 22, 2007·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Gülseren BaranMustafa A Cevik
Mar 3, 2007·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·L-C KuoP-R Hsueh
Aug 2, 2014·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Hsin-Hao LaiChang-Phone Fung
Feb 18, 2010·Computers & Chemical Engineering·P T FoteinouI P Androulakis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
V M ManikalJ Quale
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
G Christopher WoodBradley A Boucher
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
M del Mar TomasG Bou
© 2022 Meta ULC. All rights reserved